Garcia-Pagan JC - Search Results

1

Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.

Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, Ripoll C, Maurer R, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Makuch R, Rendon G; Portal Hypertension Collaborative Group. Qamar AA, et al. Clin Gastroenterol Hepatol. 2009 Jun;7(6):689-95. doi: 10.1016/j.cgh.2009.02.021. Epub 2009 Mar 10. Clin Gastroenterol Hepatol. 2009. PMID: 19281860 Free PMC article.

2

Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.

García-Pagán JC, Navasa M, Rivera F, Bosch J, Rodés J. García-Pagán JC, et al. Gastroenterology. 1992 Jun;102(6):2015-23. doi: 10.1016/0016-5085(92)90327-u. Gastroenterology. 1992. PMID: 1316859

3

[Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].

Navasa M, García-Pagán JC, Bosch J, Rodés J. Navasa M, et al. Med Clin (Barc). 1992 Feb 29;98(8):290-4. Med Clin (Barc). 1992. PMID: 1560714 Spanish.

4

Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.

La Villa G, Salmerón JM, Arroyo V, Bosch J, Ginés P, García-Pagán JC, Ginés A, Asbert M, Jiménez W, Rivera F, et al. La Villa G, et al. Gastroenterology. 1992 Jun;102(6):2114-9. doi: 10.1016/0016-5085(92)90340-5. Gastroenterology. 1992. PMID: 1587432

5

Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.

Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta MP, Bosch J, Rodés J. Ruiz del Arbol L, et al. J Hepatol. 1991 Sep;13(2):179-86. doi: 10.1016/0168-8278(91)90812-p. J Hepatol. 1991. PMID: 1744422 Clinical Trial.

6

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.

García-Pagán JC, Feu F, Bosch J, Rodés J. García-Pagán JC, et al. Ann Intern Med. 1991 May 15;114(10):869-73. doi: 10.7326/0003-4819-114-10-869. Ann Intern Med. 1991. PMID: 2014947 Clinical Trial.

7

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J. García-Pagán JC, et al. J Hepatol. 1990 Sep;11(2):189-95. doi: 10.1016/0168-8278(90)90112-5. J Hepatol. 1990. PMID: 2123914 Clinical Trial.

8

Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.

Bosch J, Groszmann RJ, García-Pagán JC, Terés J, García-Tsao G, Navasa M, Mas A, Rodés J. Bosch J, et al. Hepatology. 1989 Dec;10(6):962-8. doi: 10.1002/hep.1840100612. Hepatology. 1989. PMID: 2511136 Clinical Trial.

9

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.

Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, Rodés J. Feu F, et al. Lancet. 1995 Oct 21;346(8982):1056-9. doi: 10.1016/s0140-6736(95)91740-3. Lancet. 1995. PMID: 7564785 Clinical Trial.

10

Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.

Cirera I, Feu F, Luca A, García-Pagán JC, Fernández M, Escorsell A, Bosch J, Rodés J. Cirera I, et al. Hepatology. 1995 Jul;22(1):106-11. Hepatology. 1995. PMID: 7601400 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

479 results

Search Page

Filters